In I971 there were I7,656 deaths from ischaemic heart disease in Scotland. This accounted for per cent of all deaths, I in 3 male and I in 4 female deaths in the country (Registrar General, I972) .
Epidemiological studies have indicated that hyperlipidaemia as shown by raised cholesterol or raised triglyceride, either singly or in combination, hypertension, and heavy cigarette smoking are among the major risk factors in the development of coronary heart disease (Blackburn, I970; Carlson and Bottiger, I972; Kannel et al., I964) . Advances in the study of hyperlipidaemia have led to the concept of the hyperlipoproteinaemias and to the development of lipoprotein typing systems, such as described by Fredrickson, Levy, and Lees (I967) . There is, however, as yet little knowledge of the frequency with which lipoprotein abnormalities occur in the population in this country.
This study was, therefore, undertaken to investigate the prevalence of lipoprotein abnormalities in apparently healthy male subjects at work in the Glasgow conurbation of the West of Scotland, an area where there is a high incidence of coronary heart disease.
Methods

Sample and response
The sample consisted of apparently healthy men, either self-employed or on the staff of professional or industrial groups. The survey comprised 4477 men (a response rate of 77%). They were mainly between the ages of 35 and 59 years and were in employment as shown (Table i ). There were 2346 (52 3%) non-manual and 2131 (4j 7%) manual workers. Before attending the screening unit, each subject was asked to complete a Normal and abnormal participants The total population examined (4477) was divided into two subgroups designated 'normal' and 'abnormal'. The abnormal group contained subjects with any of the following conditions which were present in the proportion shown in Table 2 . The following definitions were used: Cigarette smoking -5 or more cigarettes daily. Obesity -more than I0 per cent above predicted ideal weight. Hypertension -systolic blood pressure of more than I70 mmHg and/or diastolic blood pressure of more than ioo mmHg at time of study. Electrocardiographic abnormalities were those summarized as categories I and II in the Minnesota code. (Minnesota code I: major Q wave or left bundle-branch block, groups i*i or I 2 or 7 I. Minnesota code II: Minor Q wave, group I-3, or ST depression groups, 4-1 or 4-2 or 4-3, or T wave abnormality, groups 5-I or 5-2 or 5-3.) A history of possible angina was obtained from the questionnaire.
Of the total group, 29-5 per cent were defined as normal using the above criteria. (Wood et al., 1972) and Stockholm (Carlson and Lindstedt, I969) .
Data analysis
Age-related plasma cholesterol and triglyceride values in subjects selected as normal on the basis of the same criteria in Glasgow as used in Stockholm show similar trends. The higher levels in California may be partly due to the fact that their subjects were non-fasting (2 slices of dry toast and fruit juice before venous sampling) and that obese subjects were not excluded from their normal group. Obesity has a considerable influence on the prevalence of hypertriglyceridaemia. Table 4 shows that the mean plasma triglyceride values for obese, but otherwise normal individuals, are 20 to 30 mg/ I00 ml higher than for non-obese, normal subjects. Obesity does not appear to affect plasma cholesterol levels. Comparison with other investigations is, therefore, difficult unless normal, non-obese subjects have been studied. The apparent increase in triglyceride levels in California as compared to kyperlipoproteinaemia in apparently healthy men I95 Glasgow and Stockholm can thus perhaps be related to the inclusion of obese subjects in their normal group.
The classification of hyperlipidaemia in terms of the hyperlipoproteinaemias has given a fresh stimulus to the study of the relation between plasma lipids and vascular disease. At present there is no general agreement as to the best method of classification, or what should be regarded as the upper limits of normal for the major plasma lipoprotein fractions (high density lipoprotein, low density lipoprotein, and very low density lipoprotein). Agreement as to classification and levels of normality are needed for consistency in determination of the prevalence of hyperlipoproteinaemias in the community and for comparison with results obtained elsewhere. In addition, there are major technical and methodological problems which contribute to the relative scarcity of published data regarding the prevalence of the hyperlipoproteinaemias. Various reports have, however, appeared. Thus, Wood et al. (I972) using age related upper normal limits for cholesterol and triglyceride reported overall prevalence rates in a 'normal' group (which did not exclude obese individuals) of 2-8 per cent for type II and I3 per cent for type IV hyperlipoproteinaemia. In the Glasgow group the overall prevalence rate of type II abnormality was 3.3 per cent, and I2 per cent for type IV abnormality. When, however, the normal group is considered separately, then the prevalence rates remain at around 3-I per cent for type II abnormality and fall to 7 per cent for type IV abnormality. The apparent decrease in the prevalence of the hyperlipoproteinaemias in the older age groups may well be related to the fact that the upper limits for normal cholesterol values reported by Fredrickson et al. (I967) for a group of American men are higher than those found in the West of Scotland. It is likely that the prevalence of plasma lipoprotein disorders in the community can be adequately studied only when normal values, based on quantitative measurements, are determined.
In assessing these results it should be emphasized that this is not a random sample of the general population, though it does represent an important economic group in the community. In addition, the use of total plasma cholesterol levels in the classification of type IIa hyperlipoproteinaemia may underestimate the prevalence of this abnormality. It must also be conceded that a high prevalence of hyperlipoproteinaemia in an area where there is a high incidence of coronary disease does not mean that they are causally related. Their clinical significance could best be determined by large scale, longterm prospective studies of 'at risk groups' or by demonstrating that the correction of lipoprotein abnormalities results in a reduction in the clinical manifestations of coronary heart disease in the community.
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